Details of the Drug
General Information of Drug (ID: DMF3CLX)
Drug Name |
4-Iodopyrazole
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Iodopyrazole; 4-Iodo-1H-pyrazole; 3469-69-0; 1H-Pyrazole, 4-iodo-; 4-iodo-pyrazole; Pyrazole, 4-iodo; LLNQWPTUJJYTTE-UHFFFAOYSA-N; 4-Iodopyrazole, 98%; 4-iod-1h-pyrazol; 4-iodo pyrazole; sFtHCQVILimKP@; zlchem 55; EINECS 222-434-1; 4-iodo-1H-pyrazol; PubChem13295; ACMC-1CSZW; 4-Iodopyrazole, 99%; AC1Q4PAD; AC1L2S6R; AC1Q1GT3; SCHEMBL71959; AMTH001; KSC225I2F; Jsp006281; LLNQWPTUJJYTTE-UHFFFAOYSA-; CTK1C5422; CHEBI:45260; ZLB0042; DTXSID30188244; MolPort-000-156-497; BM019; KS-000004PJ; ALBB-013400; ACT01776; ZINC2046962; ACN-P000781
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 193.97 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||